YEAR | COMPANY | POSITION | SALARY | INCREMENT |
---|---|---|---|---|
2025 | Arcus Biosciences Inc | Director | - | - |
2025 | ArriVent BioPharma Inc. | Independent Director | - | - |
2025 | Ardelyx Inc | Independent Director | - | - |
2025 | Sagimet Biosciences Inc - Ordinary Shares - Class A | Independent Director | - | - |
2024 | Sagimet Biosciences Inc - Ordinary Shares - Class A | Independent Director | 227.7 K | 448.6 % |
2024 | Arcus Biosciences Inc | Director | - | - |
2024 | ArriVent BioPharma Inc. | Independent Director | - | - |
2024 | Ardelyx Inc | Independent Director | - | - |
2023 | Sagimet Biosciences Inc - Ordinary Shares - Class A | - | 41.5 K | 3.8 % |
2022 | Sagimet Biosciences Inc - Ordinary Shares - Class A | Independent Director | 40 K | - |
2022 | Arcus Biosciences Inc | Director | - | - |
2021 | Arcus Biosciences Inc | Director | - | - |
2020 | Arcus Biosciences Inc | Director | - | - |